Proto Script Pharmaceutical Corp.
Proto Script Pharmaceutical Corp.
Your view on PSCR
Overview
What the company does, where it operates, and who runs it.
About Proto Script Pharmaceutical Corp.
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Michelle Rico
- Headquarters
- 9830 6th Street, Rancho Cucamonga, CA, US
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Michelle Rico
- Headquarters
- 9830 6th Street, Rancho Cucamonga, CA, US
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Proto Script Pharmaceutical Corp., and the rating behind it. PSCR last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Proto Script Pharmaceutical Corp.. Starting points for Proto Script Pharmaceutical Corp.: EPS -$0.08, beta 6.35 — an Specialty Business Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Proto Script Pharmaceutical Corp.. Proto Script Pharmaceutical Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Proto Script Pharmaceutical Corp.. Trailing twelve-month EPS for Proto Script Pharmaceutical Corp. stands at -$0.08. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Proto Script Pharmaceutical Corp.. Proto Script Pharmaceutical Corp. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Proto Script Pharmaceutical Corp. valued side by side against its closest peers. Proto Script Pharmaceutical Corp. is measured against Specialty Business Services peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Proto Script Pharmaceutical Corp., and how their positions are changing. At a $4,914 market value, institutional positions materially move Proto Script Pharmaceutical Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Proto Script Pharmaceutical Corp. executives and directors. Shares of Proto Script Pharmaceutical Corp. have traded between $0.0001 and $0.0011 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Proto Script Pharmaceutical Corp.. Proto Script Pharmaceutical Corp. is a $4,914 Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Proto Script Pharmaceutical Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Proto Script Pharmaceutical Corp.. Coverage tracks Proto Script Pharmaceutical Corp. within Specialty Business Services (Industrials). Press releases and market coverage, newest first.